Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma.

Samar Ibrahim Amer Ismail Engy Talaat HelmyAhmed Mahmoud Abdel AzizPassant Essam Eldin Shibel

Published in: Asian Pacific journal of cancer prevention : APJCP (2023)

Perlecan expression measured by immunohistochemical staining is associated with aggressive characteristics in breast cancer, suggesting that Perlecan may help in cancer progression and can be investigated as a possible target therapy.

Keyphrases

poor prognosis
papillary thyroid
binding protein
long non coding rna
squamous cell carcinoma
stem cells
young adults
mesenchymal stem cells
mass spectrometry
atomic force microscopy
childhood cancer
lymph node metastasis
replacement therapy